Trial · NCT03257631
Results by group62
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 62
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants With an Objective Response and Long-term Stable Disease | Diffuse Intrinsic Pontine Glioma | 0 | 95% Confidence Interval 0.0 to 33.6 | percentage of participants | |
| Percentage of Participants With an Objective Response and Long-term Stable Disease | Ependymoma | 11.1 | 95% Confidence Interval 0.3 to 48.2 | percentage of participants | |
| Percentage of Participants With an Objective Response and Long-term Stable Disease | High-grade Glioma | 10.5 | 95% Confidence Interval 1.3 to 33.1 | percentage of participants | |
| Percentage of Participants With an Objective Response and Long-term Stable Disease | Medulloblastoma | 0 | 95% Confidence Interval 0.0 to 33.6 | percentage of participants | |
| Percentage of Participants Who Achieved an Objective Response (ORR) | Diffuse Intrinsic Pontine Glioma | 0 | 95% Confidence Interval 0.0 to 33.6 | percentage of participants | |
| Percentage of Participants Who Achieved an Objective Response (ORR) | Ependymoma | 0 | 95% Confidence Interval 0.0 to 33.6 | percentage of participants | |
| Percentage of Participants Who Achieved an Objective Response (ORR) | High-grade Glioma | 5.3 | 95% Confidence Interval 0.1 to 26.0 | percentage of participants | |
| Percentage of Participants Who Achieved an Objective Response (ORR) | Medulloblastoma | 0 | 95% Confidence Interval 0.0 to 33.6 | percentage of participants | |
| Percentage of Participants With Long-term Stable Disease | Diffuse Intrinsic Pontine Glioma | 0 | 95% Confidence Interval 0.0 to 33.6 | percentage of participants | |
| Percentage of Participants With Long-term Stable Disease | Ependymoma | 11.1 | 95% Confidence Interval 0.3 to 48.2 | percentage of participants | |
| Percentage of Participants With Long-term Stable Disease | High-grade Glioma | 5.3 | 95% Confidence Interval 0.1 to 26.0 | percentage of participants | |
| Percentage of Participants With Long-term Stable Disease | Medulloblastoma | 0 | 95% Confidence Interval 0.0 to 33.6 | percentage of participants | |
| Duration of Response (DoR) | Diffuse Intrinsic Pontine Glioma | 12.29 | 95% Confidence Interval NA to NA | weeks | |
| Duration of Response (DoR) | High-grade Glioma | NA | 95% Confidence Interval NA to NA | weeks | |
| Kaplan-Meier Estimate of Progression-Free Survival (PFS) | Diffuse Intrinsic Pontine Glioma | 11.43 | 95% Confidence Interval 4.43 to 12.57 | weeks | |
| Kaplan-Meier Estimate of Progression-Free Survival (PFS) | Ependymoma | 8.43 | 95% Confidence Interval 5.57 to 16.14 | weeks | |
| Kaplan-Meier Estimate of Progression-Free Survival (PFS) | High-grade Glioma | 7.86 | 95% Confidence Interval 5.43 to 8.29 | weeks | |
| Kaplan-Meier Estimate of Progression-Free Survival (PFS) | Medulloblastoma | 8.29 | 95% Confidence Interval 7.29 to 18.00 | weeks | |
| Kaplan-Meier Estimate of Overall Survival (OS) | Diffuse Intrinsic Pontine Glioma | 4.86 | 95% Confidence Interval 1.02 to 10.91 | months | |
| Kaplan-Meier Estimate of Overall Survival (OS) | Ependymoma | 12.02 | 95% Confidence Interval 2.86 to 20.90 | months |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03257631/results